Clearing the path to clinical trials
Capsule availability is often a hidden bottleneck in early clinical development. The new Capsugel® CapsuleCaddy® program, available for customers located in EMEA, removes that barrier, giving you immediate access to GMP capsules in clinically relevant quantities, so you can move from formulation to first-in-human faster.
Download the brochure to learn more about the CapsuleCaddy® options available from stock, supporting diverse formulation strategies and clinical requirements.
* Please note that this program is for EMEA customers only, contact your customer representative to learn more about the CapsuleCaddy® program available in other regions
Latest CHI content